| Literature DB >> 20153104 |
Toshiaki Ohara1, Munenori Takaoka, Kazufumi Sakurama, Kaori Nagaishi, Haruo Takeda, Yasuhiro Shirakawa, Tomoki Yamatsuji, Takeshi Nagasaka, Junji Matsuoka, Noriaki Tanaka, Yoshio Naomoto.
Abstract
We established a promising new experimental animal model with an orthotopic xenograft of esophageal cancer that successfully represents poor oral intake, a major clinical feature of esophageal cancer. The advantage of this model is that no surgical technique is required, only the injection of a cell suspension by a needle and syringe via the esophageal lumen from the mouth, which provides a high reproducibility of tumor implantation and a rapid progress of outcome. We propose that this model is useful to study cancer-related outcomes and for developing new therapies for esophageal cancer, and we expect it to make a contribution to clinical practice. Copyright 2010 Elsevier Ireland Ltd. All rights reserved.Entities:
Mesh:
Year: 2010 PMID: 20153104 DOI: 10.1016/j.canlet.2010.01.017
Source DB: PubMed Journal: Cancer Lett ISSN: 0304-3835 Impact factor: 8.679